
Most common adverse reactions (≥5%) are peripheral edema, hypotension (including orthostatic hypotension), dizziness, hyperkalemia, and anemia.
from FDA,2023.02
During treatment with Sparsentan, regular monitoring is required. Follow-up should be conducted before treatment and monthly for the first 12 months, followed by evaluations every ···【more】
Article source:Lucius LaosRelease date:2026-03-18Recommended:44

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: